- Home
- CRBP vs JILL Comparison
CRBP vs JILL Comparison
Compare CRBP & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- JILL
- Stock Information
- Founded
- CRBP 2009
- JILL 1959
- Country
- CRBP United States
- JILL United States
- Employees
- CRBP N/A
- JILL N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- JILL Clothing/Shoe/Accessory Stores
- Sector
- CRBP Health Care
- JILL Consumer Discretionary
- Exchange
- CRBP Nasdaq
- JILL Nasdaq
- Market Cap
- CRBP 210.8M
- JILL 233.1M
- IPO Year
- CRBP N/A
- JILL 2017
- Fundamental
- Price
- CRBP $11.23
- JILL $14.94
- Analyst Decision
- CRBP Strong Buy
- JILL Buy
- Analyst Count
- CRBP 9
- JILL 4
- Target Price
- CRBP $48.38
- JILL $20.00
- AVG Volume (30 Days)
- CRBP 546.2K
- JILL 45.4K
- Earning Date
- CRBP 11-12-2025
- JILL 12-10-2025
- Dividend Yield
- CRBP N/A
- JILL 2.15%
- EPS Growth
- CRBP N/A
- JILL N/A
- EPS
- CRBP N/A
- JILL 2.39
- Revenue
- CRBP N/A
- JILL $601,713,000.00
- Revenue This Year
- CRBP N/A
- JILL $0.87
- Revenue Next Year
- CRBP $220.00
- JILL $2.44
- P/E Ratio
- CRBP N/A
- JILL $6.24
- Revenue Growth
- CRBP N/A
- JILL N/A
- 52 Week Low
- CRBP $4.64
- JILL $13.32
- 52 Week High
- CRBP $20.56
- JILL $30.40
- Technical
- Relative Strength Index (RSI)
- CRBP 38.90
- JILL 51.00
- Support Level
- CRBP $10.88
- JILL $13.32
- Resistance Level
- CRBP $12.43
- JILL $14.44
- Average True Range (ATR)
- CRBP 0.76
- JILL 0.50
- MACD
- CRBP 0.05
- JILL 0.04
- Stochastic Oscillator
- CRBP 51.59
- JILL 72.00
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.